Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/12/1999CA2274638A1 Aromatic heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions made thereof and uses
12/12/1999CA2274202A1 Diaza-spiro[3,5]nonane derivatives
12/09/1999WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection
12/09/1999WO1999063079A1 Endometriosis-associated gene
12/09/1999WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062914A1 Cyclic boroproline compounds
12/09/1999WO1999062910A1 Process for preparing crystalline salts of amoxycillin
12/09/1999WO1999062909A2 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/09/1999WO1999062908A2 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999WO1999062907A1 Fused phenoxymethyl carbapenem antibacterials
12/09/1999WO1999062906A1 Benzothiazolythiomethyl carbapenem antibacterial
12/09/1999WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999WO1999062902A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999WO1999062901A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999WO1999062899A1 Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
12/09/1999WO1999062897A1 Hiv integrase inhibitors
12/09/1999WO1999062896A1 Novel polyoxypropylenepolyoxyethylene vitamin e and preparation thereof
12/09/1999WO1999062893A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
12/09/1999WO1999062891A1 Potassium channel inhibitors
12/09/1999WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999WO1999062888A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999WO1999062887A1 Cyanoiminoquinoxaline derivatives
12/09/1999WO1999062885A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999WO1999062884A1 Pyrazoline derivatives, their preparation and application as medicaments
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062882A1 Substituted indolinones, the production thereof and their use as medicaments
12/09/1999WO1999062881A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999WO1999062880A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999WO1999062879A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999WO1999062878A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/09/1999WO1999062876A1 24,24-difluorinated analogs of 1-alpha,25-dihydroxy vitamin d3
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062873A1 Benzenesulphonamide derivatives as pyruvate dehydrogenase activators
12/09/1999WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999WO1999062871A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999WO1999062870A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999WO1999062560A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999WO1999062559A1 Pharmaceutical tablets comprising cefuroxime axetil
12/09/1999WO1999062557A1 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
12/09/1999WO1999062555A1 Remedies for itching containing pgd2 antagonists
12/09/1999WO1999062553A1 Remedies for male sterility
12/09/1999WO1999062551A1 Texaphyrin conjugates and uses thereof
12/09/1999WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999WO1999062531A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999WO1999062530A1 Simmondsin concentrate from jojoba
12/09/1999WO1999062528A1 Treatment of arthritis and other similar conditions
12/09/1999WO1999062527A1 nrdE
12/09/1999WO1999062525A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999WO1999062524A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062522A1 Combination therapy for treatment of bipolar disorders
12/09/1999WO1999062521A1 Composition comprising 7beta-[2-(2- aminothiazol- 4-yl)-(z)-2- hydroxyiminoacetamido] -3-[(5-methyl- 1, 3, 4-thiadiazol- 2-yl)thiomethyl] -3- cephem-4- carboxilic acid for treating mastitis for livestock
12/09/1999WO1999062519A1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
12/09/1999WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999WO1999062517A1 METHOD OF ENHANCING LYSOSOMAL α-GALACTOSIDASE A
12/09/1999WO1999062516A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
12/09/1999WO1999062515A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
12/09/1999WO1999062513A1 Hiv integrase inhibitors
12/09/1999WO1999062511A1 Neurotrophic difluoroamide agents
12/09/1999WO1999062510A2 Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
12/09/1999WO1999062509A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999WO1999062508A1 A new use for glycine
12/09/1999WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999WO1999062503A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999WO1999062502A2 Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999062497A1 Stable gel mixture in the form of a mixture of oleogel and aqueous gel
12/09/1999WO1999062496A1 Methods and devices for providing prolonged drug therapy
12/09/1999WO1999062495A2 Dry powder dispersing apparatus and methods for their use
12/09/1999WO1999062491A1 Small molecule pipecolic acid derivative hair growth compositions and uses
12/09/1999WO1999062490A1 Small molecule sulfonamide hair growth compositions and uses
12/09/1999WO1999062489A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/09/1999WO1999062488A1 Heterocyclic thioester and ketone hair growth compositions and uses
12/09/1999WO1999062487A1 Heterocyclic ester and amide hair growth compositions and uses
12/09/1999WO1999062486A1 N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
12/09/1999WO1999062485A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
12/09/1999WO1999062484A1 Small molecule carbamate or urea hair growth compositions and uses
12/09/1999WO1999062483A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999WO1999062479A1 Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism
12/09/1999WO1999062475A1 Anti-germ attachment - composition
12/09/1999WO1999062474A1 Anti-germ attachment - composition
12/09/1999WO1999062463A1 α-HYDROXY FATTY ACID DERIVATIVES AND COMPOSITION FOR EXTERNAL USE CONTAINING THE SAME
12/09/1999WO1999062459A2 Agents and methods for protection, treatment and repair of connective tissue
12/09/1999WO1999062451A1 Topical transdermal treatments
12/09/1999WO1999062444A1 Silk clothes for protecting affected parts
12/09/1999WO1999062359A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999WO1999062336A1 Methods and compositions for controlling iron stores to treat and cure disease states and reduce aging
12/09/1999WO1999056729B1 Cholesterol lowering composition
12/09/1999WO1999053909A3 Pharmaceutical composition for neurotrophic action
12/09/1999WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
12/09/1999WO1999051617A3 FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
12/09/1999WO1999051591A3 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
12/09/1999WO1999051260A3 Treatment of cardiac hypertrophy
12/09/1999WO1999047507A3 1,3,4-thiadiazoles useful for the treatment of cmv infections
1 ... 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 ... 7860